CELH
Celsius Holdings, Inc.
CELH has lower modeled downside risk, despite its lower overall score.
JVA
Coffee Holding Co., Inc.
JVA has a slight edge over CELH overall, supported by stronger valuation.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
JVA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
JVA's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
JVA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 6.2x | $5.17 | — |
| Cheap | 11x | $9.53 | +84% |
| Fair | 20x | $16.82 | +225% |
| Expensive | 48x | $40.08 | +675% |
Historical ranges are pointers, not guarantees.
JVA has the edge over CELH in the historical PE scenario, which offers more potential upside but is not a forecast.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
JVA Forward outlook
There aren't enough analyst estimates for JVA to show an outlook.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
JVA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.84 | +163% |
| Q2 2026 | $0.28 | -56% |
| Q1 2026 | $0.34 | -36% |
| Q4 2025 | $0.25 | -36% |
| Q3 2025 | $0.32 | +68% |
| Q2 2025 | $0.64 | +967% |
| Q1 2025 | $0.53 | +$0.53 |
| Q4 2024 | $0.39 | +$0.54 |
JVA has the edge over CELH on earnings, with more consistent year-over-year improvement.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over JVA on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over JVA on profitability, with a higher operating margin.
JVA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $21.7M | -9.3% |
| Q2 2026 | $22.1M | -5.1% |
| Q1 2026 | $25.6M | +20% |
| Q4 2025 | $27.7M | +31% |
| Q3 2025 | $23.9M | +27% |
| Q2 2025 | $23.3M | +23% |
| Q1 2025 | $21.3M | +9% |
| Q4 2024 | $21.2M | +13% |
JVA's revenue is growing: $22M last quarter, down 9.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | +15 points |
| Q2 2026 | 1.6% | -2.3 points |
| Q1 2026 | 9.3% | +1.8 points |
| Q4 2025 | 2.8% | -5.2 points |
| Q3 2025 | -4.6% | -8.4 points |
| Q2 2025 | 3.8% | +4.2 points |
| Q1 2025 | 7.5% | +4.3 points |
| Q4 2024 | 8% | +6.6 points |
JVA's operating margin was 11% last quarter, up 15 points from the same quarter a year ago, near the top of its range since 2019.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
JVA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.1M | +$5M |
| Q2 2026 | $44.1K | +$1.2M |
| Q1 2026 | $6.6M | +$7M |
| Q4 2025 | $265.4K | +43% |
| Q3 2025 | -$3.9M | -319% |
| Q4 2024 | $185.7K | +$468.9K |
| Q3 2024 | $1.8M | +$2.3M |
| Q4 2023 | -$283.1K | +$2M |
JVA has the edge over CELH on cash flow, with more consistent year-over-year improvement.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over JVA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
JVA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | 0% | -- |
| 3 years | 0% | -- |
| 5 years | 0% | -- |
| Available history | +2.5% | +139K shares |
JVA has 6M diluted shares, about the same as a year ago.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has the edge over JVA on leverage, with a lower net debt burden relative to earnings.
JVA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.9x | Very low |
| Q1 2026 | 0.7x | Very low |
| Q4 2025 | 4.0x | Elevated |
| Q3 2025 | 3.1x | Elevated |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | -0.4x | Net Cash |
JVA's net debt is less than a year of its operating earnings (EBITDA), down from 3.1 years a year ago.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
JVA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.8 | Neutral |
| Stochastic | 90.2 | Overbought |
JVA's weekly RSI is 69 (neutral) and its Stochastic is 90 (overbought).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
JVA PE vs Consumer Defensive Sector
| Metric | JVA | Sector median | Relative |
|---|---|---|---|
| PE | 6.2x | 19x | 68% below |
| PE % | 5 | 18 | 13 pts below |
JVA has the edge over CELH on valuation relative to its sector.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
JVA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.60 | 12% above |
| 20 week MA | $3.98 | 30% above |
| 50 week MA | $3.91 | 32% above |
| 100 week MA | $4.08 | 27% above |
| 200 week MA | $2.93 | 76% above |
JVA has the edge over CELH on trend strength, trading above more of its moving averages.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
JVA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $4.67 | $3.91 | -16% |
| 2021 | $3.91 | $4.35 | +11% |
| 2022 | $4.35 | $1.86 | -57% |
| 2023 | $1.86 | $0.91 | -51% |
| 2024 | $0.91 | $3.84 | +322% |
| 2025 | $3.84 | $4.12 | +7.3% |
| 2026 YTD | $4.12 | $5.17 | +25% |
JVA has the edge over CELH on returns for 2026, with the stronger performance.